Abstract
Intramuscular injection of nerve growth factor (NGF) has been shown to induce long-term sensitisation and time-dependent hyperalgesia indicating potential involvement of both central and peripheral pain mechanisms. This double-blind placebo-controlled study was designed to describe the spatial distribution of muscle hyperalgesia over time (immediately after, 3 h, 1, 4, 7 and 21 days) after injecting NGF (5 μg) into the tibialis anterior (TA) muscle, to explore possibly involved central pain mechanisms and to investigate the effect of gender on development of hyperalgesia. Totally 20 healthy volunteers (10 men and 10 women) participated in the study. An isotonic saline injection into the contralateral TA muscle served as a control condition for the NGF injection. Pressure pain thresholds (PPT) were used to test for muscle hyperalgesia along the TA (seven sites) muscle at the extensor digitorum longus and at the web between 1st and 2nd metatarsal (central involvement). One day after the NGF/control injections, hypertonic saline (0.5 ml, 5.8%) was injected into the left and right TA to study the pain response to chemical stimulation of the hyperalgesic muscle tissue. Scores on a modified Likert scale were used to assess soreness during muscle function. An area of hyperalgesia was observed locally at the injected site 3 h after injection of NGF, which expanded both proximally and distally on day 1; this effect subsided on day 4. Decreased PPT was also found between 1st and 2nd metatarsal on day 1. Hypertonic saline evoked more pain in men when injected in the NGF treated TA compared to the control leg. Injection of NGF increased muscle soreness during muscle activity for 7 days. In this material there was no gender effect of NGF-induced muscle hyperalgesia. The expansion of muscle hyperalgesia to distant areas indicates that central mechanisms are involved.
Similar content being viewed by others
References
Allen SJ, Dawbarn D (2006) Clinical relevance of the neurotrophins and their receptors. Clin Sci (Lond) 110:175–191
Amano T, Yamakuni T, Okabe N, Sakimura K, Takahashi Y (1991) Production of nerve growth factor in rat skeletal muscle. Neurosci Lett 132:5–7
Andersen H, Arendt-Nielsen L, Danneskiold-Samsøe B, Graven-Nielsen T (2006) Pressure pain sensitivity and hardness along human normal and sensitized muscle. Somatosens Mot Res 23:97–109
Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ (2000) Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284:2215–2221
Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J (1999) Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain 79:201–205
Bajaj P, Arendt-Nielsen L, Bajaj P, Madsen H (2001) Sensory changes during the ovulatory phase of the menstrual cycle in healthy women. Eur J Pain 5:135–144
Craft RM (2007) Modulation of pain by estrogens. Pain 132(Suppl 1):S3–S12
Drewes AM, Helweg-Larsen S, Petersen P, Brennum J, Andreasen A, Poulsen LH, Jensen TS (1993) McGill pain questionnaire translated into Danish: experimental and clinical findings. Clin J Pain 9:80–87
Dyck PJ, Peroutka S, Rask C, Burton E, Baker MK, Lehman KA, Gillen DA, Hokanson JL, O’Brien PC (1997) Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 48:501–505
Friess H (1999) Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg 230:615–624
Ge HY, Madeleine P, Arendt-Nielsen L (2004) Sex differences in temporal characteristics of descending inhibitory control: an evaluation using repeated bilateral experimental induction of muscle pain. Pain 110:72–78
Ge HY, Madeleine P, Cairns BE, Arendt-Nielsen L (2006) Hypoalgesia in the referred pain areas after bilateral injections of hypertonic saline into the trapezius muscles of men and women: a potential experimental model of gender-specific differences. Clin J Pain 22:37–44
Gibson W, Arendt-Nielsen L, Graven-Nielsen T (2006) Delayed onset muscle soreness at tendon-bone junction and muscle tissue is associated with facilitated referred pain. Exp Brain Res 174:351–360
Giovengo SL, Russell IJ, Larson AA (1999) Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 26:1564–1569
Graven-Nielsen T (2006) Fundamentals of muscle pain, referred pain, and deep tissue hyperalgesia. Scand J Rheumatol 35:1–43
Graven-Nielsen T, Jansson Y, Segerdahl M, Kristensen JD, Mense S, Arendt-Nielsen L, Sollevi A (2003) Experimental pain by ischaemic contractions compared with pain by intramuscular infusions of adenosine and hypertonic saline. Eur J Pain 7:93–102
Graven-Nielsen T, Mense S, Arendt-Nielsen L (2004) Painful and non-painful pressure sensations from human skeletal muscle. Exp Brain Res 159:273–283
Greenspan JD, Craft RM, LeResche L, Rendt-Nielsen L, Berkley KJ, Fillingim RB, Gold MS, Holdcroft A, Lautenbacher S, Mayer EA, Mogil JS, Murphy AZ, Traub RJ (2007) Studying sex and gender differences in pain and analgesia: a consensus report. Pain 132(Suppl 1):S26–S45
Hathway GJ, Fitzgerald M (2006) Time course and dose-dependence of nerve growth factor-induced secondary hyperalgesia in the mouse. J Pain 7:57–61
Hoheisel U, Unger T, Mense S (2005) Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain 114:168–176
Hoheisel U, Unger T, Mense S (2007) Sensitization of rat dorsal horn neurons by NGF-induced subthreshold potentials and low-frequency activation. A study employing intracellular recordings in vivo. Brain Res 1169:34–43
Horikawa M, Ebihara S, Sakai F, Akiyama M (1993a) Non-invasive measurement method for hardness in muscular tissues. Med Biol Eng Comput 31:623–627
Horikawa M, Ebihara S, Sakai F, Akiyama M (1993b) Non-invasive measurement method for hardness in muscular tissues. Med Biol Eng Comput 31:623–627
Horikawa M, Ebihara S, Sakai F, Akiyama M (1993c) Non-invasive measurement method for hardness in muscular tissues. Med Biol Eng Comput 31:623–627
Isselee H, De Laat A, Bogaerts K, Lysens R (2001) Long-term fluctuations of pressure pain thresholds in healthy men, normally menstruating women and oral contraceptive users. Eur J Pain 5:27–37
Jensen K, Andersen HØ, Olesen J, Lindblom U (1986) Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain 25:313–323
LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF (2003) Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 106:253–261
Lewin GR, Mendell LM (1993) Nerve growth factor and nociception. Trends Neurosci 16:353–359
Lewin GR, Ritter AM, Mendell LM (1992) On the role of nerve growth factor in the development of myelinated nociceptors. J Neurosci 12:1896–1905
Lewin GR, Ritter AM, Mendell LM (1993) Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13:2136–2148
Liuzzi FJ, Scoville SA, Bufton SM (1999) Effects of short-term estrogen replacement on trkA mRNA levels in axotomized dorsal root ganglion neurons. Exp Neurol 159:433–440
Melzack R (1975) Mcgill pain questionnaire—major properties and scoring methods. Pain 1:277–299
Miller LJ (2002) Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 59:603–608
Murayama M, Nosaka K, Yoneda T, Minamitani K (2000) Changes in hardness of the human elbow flexor muscles after eccentric exercise. Eur J Appl Physiol 82:361–367
Petruska JC, Mendell LM (2004) The many functions of nerve growth factor: multiple actions on nociceptors. Neurosci Lett 361:168–171
Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, Sinicropi D, Burton LE, Peroutka SJ (1994) The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 36:244–246
Pezet S, McMahon SB (2006) Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29:507–38
Reinert A, Kaske A, Mense S (1998) Inflammation-induced increase in the density of neuropeptide-immunoreactive nerve endings in rat skeletal muscle. Exp Brain Res 121:174–180
Riley JLIII, Robinson ME, Wise EA, Price DD (1999) A meta-analytic review of pain perception across the menstrual cycle. Pain 81:225–235
Sarchielli P, Alberti A, Floridi A, Gallai V (2001) Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 57:132–134
Schumacher MA, Jong BE, Frey SL, Sudanagunta SP, Capra NF, Levine JD (2000) The stretch-inactivated channel, a vanilloid receptor variant, is expressed in small-diameter sensory neurons in the rat. Neurosci Lett 287:215–218
Scoville SA, Bufton SM, Liuzzi FJ (1997) Estrogen regulates neurofilament gene expression in adult female rat dorsal root ganglion neurons. Exp Neurol 146:596–599
Slater H, Arendt-Nielsen L, Wright A, Graven-Nielsen T (2003) Experimental deep tissue pain in wrist extensors—a model of lateral epicondylalgia. Eur J Pain 7:277–288
Stohler CS, Kowalski CJ, Lund JP (2001) Muscle pain inhibits cutaneous touch perception. Pain 92:327–333
Svensson P, Wang K, Arendt-Nielsen L, Cairns BE (2008) Effects of NGF-induced muscle sensitization on proprioception and nociception. Exp Brain Res (in press)
Svensson P, Cairns BE, Wang K, Arendt-Nielsen L (2003) Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain 104:241–247
Unruh AM (1996) Gender variations in clinical pain experience. Pain 65:123–167
Ure DR, Campenot RB (1997) Retrograde transport and steady-state distribution of 125I-nerve growth factor in rat sympathetic neurons in compartmented cultures. J Neurosci 17:1282–1290
Woolf CJ (1996) Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci 351:441–448
Woolf CJ, Ma QP, Allchorne A, Poole S (1996) Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 16:2716–2723
Yamamoto M (2003) Pain-related differential expression of NGF, GDNF, IL-6, and their receptors in human vasculitic neuropathies. Intern Med 42:1100–1103
Acknowledgments
The authors are grateful to Dr. John Hansen (Center for Sensory-Motor Interaction (SMI), Aalborg University, Denmark) for invaluable help with software development and hardness analysis. This study was supported by the Oak Foundation, Sundheds CVU Nordjylland and the CW Obel’s Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andersen, H., Arendt-Nielsen, L., Svensson, P. et al. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans. Exp Brain Res 191, 371–382 (2008). https://doi.org/10.1007/s00221-008-1531-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00221-008-1531-5